Kymera Therapeutics, Inc.
KYMR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815442
In the last 90 days, Kymera Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 276 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Kymera Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 129
- +2 vs. Q1 2023
- Shares held
- 58.4M
- +1.56M (+2.7%) vs. Q1 2023
- Total value
- $1.34B
- −$339.6M (−20.2%) vs. Q1 2023
- New holders
- 19
- 49 more added
- Sold out
- 17
- 32 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 276 | $11.1B |
| Q1 2026 | 256 | $8.01B |
| Q4 2025 | 255 | $6.99B |
| Q3 2025 | 210 | $4.58B |
| Q2 2025 | 210 | $3.44B |
| Q1 2025 | 174 | $2.00B |
| Q4 2024 | 181 | $2.89B |
| Q3 2024 | 176 | $3.27B |
| Q2 2024 | 157 | $2.01B |
| Q1 2024 | 164 | $2.70B |
| Q4 2023 | 137 | $1.54B |
| Q3 2023 | 122 | $797.2M |
| Q2 2023 | 129 | $1.34B |
| Q1 2023 | 127 | $1.68B |
| Q4 2022 | 121 | $1.40B |
| Q3 2022 | 128 | $1.15B |
| Q2 2022 | 101 | $973.6M |
| Q1 2022 | 126 | $1.93B |
| Q4 2021 | 128 | $2.76B |
| Q3 2021 | 115 | $2.04B |
| Q2 2021 | 110 | $1.29B |
| Q1 2021 | 97 | $887.2M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Kymera Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 263,918 | $6.07M | 0.01% | +263,918 | New |
| Citadel Advisors LLC | 279,582 | $6.43M | 0.01% | +279,364+128,148.6% | Added |
| Charles Schwab Investment Management Inc | 301,102 | $6.92M | 0.00% | +2,605+0.9% | Added |
| Goldman Sachs Group Inc | 341,545 | $7.85M | 0.00% | +44,702+15.1% | Added |
| Northern Trust Corp | 354,928 | $8.16M | 0.00% | +18,101+5.4% | Added |
| Massachusetts Financial Services Co | 376,948 | $8.67M | 0.00% | +37,801+11.1% | Added |
| Barclays PLC | 384,983 | $8.85M | 0.01% | +25,055+7.0% | Added |
| Morgan Stanley | 405,905 | $9.33M | 0.00% | +79,583+24.4% | Added |
| Candriam Luxembourg S.C.A. | 488,306 | $11.2M | 0.08% | −23,170−4.5% | Reduced |
| Deer Management Co. LLC | 615,895 | $14.2M | 1.27% | 00.0% | Unchanged |
| Aquilo Capital Management, LLC | 651,325 | $15.0M | 9.83% | +50,000+8.3% | Added |
| JPMorgan Chase & Co | 655,971 | $15.1M | 0.00% | +89,005+15.7% | Added |
| Geode Capital Management, LLC | 801,285 | $18.4M | 0.00% | +20,456+2.6% | Added |
| FMR LLC | 838,212 | $19.3M | 0.00% | +170,861+25.6% | Added |
| Dimensional Fund Advisors LP | 840,938 | $19.3M | 0.01% | +100,947+13.6% | Added |
| Wasatch Advisors Inc | 1,199,350 | $27.6M | 0.17% | +161,936+15.6% | Added |
| Rock Springs Capital Management LP | 1,487,551 | $34.2M | 0.81% | +259,172+21.1% | Added |
| T. Rowe Price Investment Management, Inc. | 1,610,496 | $37.0M | 0.03% | −357,679−18.2% | Reduced |
| Artal Group S.A. | 1,805,346 | $41.5M | 1.33% | 00.0% | Unchanged |
| Redmile Group, LLC | 1,868,507 | $43.0M | 1.65% | −542,262−22.5% | Reduced |
| State Street Corp | 2,620,309 | $60.2M | 0.00% | −106,516−3.9% | Reduced |
| BlackRock Inc. | 3,225,846 | $74.2M | 0.00% | −104,344−3.1% | Reduced |
| Vanguard Group Inc | 3,743,088 | $86.1M | 0.00% | +9,163+0.2% | Added |
| Avoro Capital Advisors LLC | 3,855,000 | $88.6M | 1.20% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 4,375,340 | $100.6M | 0.58% | +1,495,515+51.9% | Added |
| BVF Inc | 4,739,004 | $108.9M | 3.04% | 00.0% | Unchanged |
| Wellington Management Group LLP | 4,822,683 | $110.9M | 0.02% | +531,665+12.4% | Added |
| Price T Rowe Associates Inc | 5,007,148 | $115.1M | 0.02% | +340,467+7.3% | Added |
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $134.7M | 16.76% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −796,093−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −84,492−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −27,032−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −25,530−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −15,524−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −10,986−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −10,333−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −9,621−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −8,772−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −8,276−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −7,478−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −7,470−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −7,100−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −2,955−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −236−100.0% | Sold out |
| Tucker Asset Management LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |